no enrollment or membership fee per published terms 6-month offer: Commercial satisfaction policy with specific adherence and documentation requirements - not a medical guarantee of weight loss results Eligibility (brand-stated): BMI 30, or BMI 27 with a qualifying comorbidity (type 2 diabetes, hypertension, dyslipidemia, sleep apnea, cardiovascular disease)
Journal of Biomaterials Science, Polymer Edition , 19 (8), 969-988
In a statement, Scott Brunner, CEO of the Alliance for Pharmacy Compounding, questioned whether the FDA's resolution of the shortage had taken into account demand for the compounded drug and "the number of patients wholl need to be transitioned from a compounded version to a FDA-approved version. "Thats likely hundreds of thousands of patients," Brunner said
Oral BPC-157 is sometimes studied for gastrointestinal indications because the peptide naturally survives the acidic stomach environment
If you experience side effects like severe nausea, vomiting, or pancreatitis symptoms (upper abdominal pain, back pain, elevated lipase) at any point during treatment, eliminate alcohol entirely until your clinician confirms it is safe to resume